Overview
Hop Tran-Cao is a Surgical Oncologist practicing medicine in Houston, Texas.
Dr. Tran-Cao is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Cancer, Familial Colorectal Cancer, Hepatectomy, and Pancreaticoduodenectomy.
He is actively involved in clinical research, co-authoring 162 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
Locations
1400 Pressler St, Houston, TX 77030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
MD Anderson
Funda Meric is a General Surgeon and a Surgical Oncologist practicing medicine in Houston, Texas. Dr. Meric is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Breast Cancer, Cholangiocarcinoma (Bile Duct Cancer), Triple-Negative Breast Cancer, and Mastectomy.
Baylor Medicine At McNair - Urology
Seth P. Lerner, MD, is Professor of Urology and holds the Beth and Dave Swalm Chair in Urologic Oncology, in the Scott Department of Urology, Baylor College of Medicine. He is Director of Urologic Oncology and the Multidisciplinary Bladder Cancer Program and Faculty Group Practice Medical Director for the Urology Clinic. He earned his medical degree from Baylor College of Medicine, completed a surgical internship at Virginia Mason Hospital in Seattle, and returned to Baylor for his residency training. He completed a two-year fellowship at the University of Southern California in urologic oncology and reconstructive surgery under Peter Jones and Don Skinner before returning to join the full-time Baylor faculty in 1992. His clinical practice, education, and research activities are devoted to urologic oncology and particularly lower and upper tract urothelial cancer. Dr. Lerner is author of more than 160 peer-reviewed articles, and co-editor of a comprehensive Textbook of Bladder Cancer. Dr. Lerner is an active member of the prestigious American Association of Genitourinary surgeons and is listed routinely among America's Top Doctors and Best Doctors in America. He established and directs the multi-disciplinary Bladder Cancer Research Program at Baylor, and his research interests include use of selective estrogen receptor modulators for treatment of bladder cancer, gene therapy, targeted molecular therapeutics, and outcomes of radical cystectomy and pelvic lymphadenectomy. He has 22 years of experience as a clinical investigator for both NCI and industry funded clinical trials. He is the PI of the ongoing SWOG NCI Phase III trial comparing extended vs. standard pelvic lymphadenectomy at time of radical cystectomy for muscle invasive bladder cancer. He is active in the leadership of several national bladder cancer research enterprises including chair of the Local Bladder Cancer committee of SWOG, co-chair of the NCI's Bladder Cancer Task Force and the Analysis Working Group of The Cancer Genome Atlas Project for muscle invasive bladder cancer. He is very active in the Bladder Cancer Advocacy Network (BCAN) as a member of the Board of Directors, past chair of the Bladder Cancer Think Tank and co-chair of the management committee of the Bladder Cancer Research Network. Dr. Lerner is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy. Dr. Lerner is currently accepting new patients.
Thomas Aloia is a Surgical Oncologist practicing medicine in Houston, Texas. Dr. Aloia is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Gallbladder Adenocarcinoma, Hepatectomy, and Hepato-Pancreato-Biliary Surgery.
UT MD Anderson Cancer Center
Naruhiko Ikoma is a Surgical Oncologist practicing medicine in Houston, Texas. Dr. Ikoma is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Stomach Cancer, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Pancreatectomy.
UT MD Anderson Cancer Center
Emily Keung is a Surgical Oncologist practicing medicine in Houston, Texas. Dr. Keung is highly rated in 23 conditions, according to our data. Her clinical expertise encompasses Undifferentiated Pleomorphic Sarcoma, Liposarcoma, Adult Soft Tissue Sarcoma, Melanoma, and Lymphadenectomy. Dr. Keung is currently accepting new patients.
Baylor St. Luke's
Dr. William E. Fisher is Professor and Vice-Chair for Clinical Affairs, Department of Surgery and the George L. Jordan, M.D. Chair in General Surgery at Baylor College of Medicine. Dr. Fisher also serves as Director of the Elkins Pancreas Center at BCM; and is Vice President, Medical Staff and Chief of the Surgery Service Line at Baylor St. Luke’s Medical Center.An internationally-known leader in pancreatic surgery, Dr. Fisher has focused entirely on surgery for pancreatic tumors and cysts in his practice for over 20 years and has extensive experience in advanced, minimally-invasive robotic pancreas surgery.Dr. Fisher’s professional interests include: pancreaticoduodenectomy (Whipple procedure); minimally invasive/laparoscopic/robotic pancreatic surgery; pancreas cancer; distal and central pancreatectomy; pancreas resection; surgical oncology; common bile duct resection; Puestow procedure; Frey procedure; and laparoscopic pancreatectomy.Dr. Fisher has served as PI of two NIH-funded multicenter randomized clinical trials that generated practice-changing impact on the use of drains during pancreatectomy, and the subsequent development of a multicenter pancreatic-surgery-outcomes consortium. His basic science lab has studied the influence of gastrointestinal hormones on pancreatic cancer growth, the relationship between diabetes and pancreatic cancer, and genomic analysis of pancreatic cancer, resulting in over 160 peer-reviewed publications.Having served as principal investigator on more than 15 clinical trials for patients with pancreatic cancer, Dr. Fisher is currently PI at BCM for the NIH Consortium to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer.Dr. Fisher received a B.A. from Wittenberg University and earned his medical degree from the University of Cincinnati College of Medicine. He held a research fellowship and completed his residency at The Ohio State University.Among his numerous honors and awards, Dr. Fisher has been recognized as one of America’s Top Doctors for Cancer (Castle Connolly Medical Ltd.), Top 1% of Doctors in the U.S. (U.S. News and World Report), and “Texas Super Doctor” (Texas Monthly). He is also the recipient of the Master Clinician Award for Excellence in Patient Care from BCM and has twice received the DeBakey Distinguished Service Award from the Michael E. DeBakey Department of Surgery at BCM. Dr. Fisher is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Chronic Pancreatitis, Pancreatic Cancer, Hereditary Pancreatitis, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Fisher is currently accepting new patients.
Frequently Asked Questions about Dr. Hop S. Tran-Cao
How do I make an appointment with Dr. Hop S. Tran-Cao?
You can book an appointment with Dr. Hop S. Tran-Cao by calling their office at 713-792-6940. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Hop S. Tran-Cao a top-rated expert for Cholangiocarcinoma (Bile Duct Cancer)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Hop S. Tran-Cao is classified as an Distinguished expert for Cholangiocarcinoma (Bile Duct Cancer), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Hop S. Tran-Cao specialize in?
While Dr. Hop S. Tran-Cao is a Surgical Oncology, they have specific expertise in Cholangiocarcinoma (Bile Duct Cancer), Hepatectomy, and Pancreaticoduodenectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Surgical Oncology.
Does Dr. Hop S. Tran-Cao participate in research or clinical trials?
Yes. Dr. Hop S. Tran-Cao has published 162 articles and abstracts on conditions like Cholangiocarcinoma (Bile Duct Cancer). You can view a list of Dr. Hop S. Tran-Cao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Hop S. Tran-Cao accept my insurance?
Dr. Hop S. Tran-Cao accepts most major insurance plans, including Blue Cross Blue Shield and Health Care Services Corporation. We recommend calling the office directly at 713-792-6940 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Cholangiocarcinoma (Bile Duct Cancer)Dr. Tran-Cao isDistinguished. Learn about Cholangiocarcinoma (Bile Duct Cancer).
- HepatectomyDr. Tran-Cao isDistinguished. Learn about Hepatectomy.
- Advanced
- Colorectal CancerDr. Tran-Cao isAdvanced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Tran-Cao isAdvanced. Learn about Familial Colorectal Cancer.
- Fibrolamellar CarcinomaDr. Tran-Cao isAdvanced. Learn about Fibrolamellar Carcinoma.
- Gallbladder AdenocarcinomaDr. Tran-Cao isAdvanced. Learn about Gallbladder Adenocarcinoma.
- Gallbladder CancerDr. Tran-Cao isAdvanced. Learn about Gallbladder Cancer.
- Hepato-Pancreato-Biliary SurgeryDr. Tran-Cao isAdvanced. Learn about Hepato-Pancreato-Biliary Surgery.
- Liver CancerDr. Tran-Cao isAdvanced. Learn about Liver Cancer.
- PancreatectomyDr. Tran-Cao isAdvanced. Learn about Pancreatectomy.
- Pancreatic CancerDr. Tran-Cao isAdvanced. Learn about Pancreatic Cancer.
- PancreaticoduodenectomyDr. Tran-Cao isAdvanced. Learn about Pancreaticoduodenectomy.
- Experienced
- Bile Duct CystsDr. Tran-Cao isExperienced. Learn about Bile Duct Cysts.
- EndoscopyDr. Tran-Cao isExperienced. Learn about Endoscopy.
- Febrile NeutropeniaDr. Tran-Cao isExperienced. Learn about Febrile Neutropenia.
- Gallbladder DiseaseDr. Tran-Cao isExperienced. Learn about Gallbladder Disease.
- Gallbladder RemovalDr. Tran-Cao isExperienced. Learn about Gallbladder Removal.
- Gastroesophageal Junction CancerDr. Tran-Cao isExperienced. Learn about Gastroesophageal Junction Cancer.
- Liver EmbolizationDr. Tran-Cao isExperienced. Learn about Liver Embolization.
- LymphadenectomyDr. Tran-Cao isExperienced. Learn about Lymphadenectomy.
- Neuroendocrine TumorDr. Tran-Cao isExperienced. Learn about Neuroendocrine Tumor.
- PIK3CA-Related Overgrowth SpectrumDr. Tran-Cao isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Progressive Familial Intrahepatic Cholestasis Type 2
- Progressive Familial Intrahepatic Cholestasis Type 3
- Small Bowel ResectionDr. Tran-Cao isExperienced. Learn about Small Bowel Resection.
- Squamous Cell Carcinoma of the Anal Canal (SCAC)
- Stomach CancerDr. Tran-Cao isExperienced. Learn about Stomach Cancer.


